Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Marinol in Trichotillomania or Obsessive Compulsive Disorder

Phase 2

Completed

Conditions: Obsessive Compulsive Disorder
Trichotillomania

Interventions: Drug: Dronabinol

First Posted Date: 2010-03-26

Last Posted Date: 2023-02-23

Lead Sponsor: University of Chicago

Target Recruit Count: 14

Registration Number: NCT01093976

Locations: 🇺🇸
Ambulatory Research Center, Minneapolis, Minnesota, United States

Improving Diabetes Care and Outcomes on the South Side of Chicago

Not Applicable

Completed

Conditions: Diabetes Mellitus

Interventions: Behavioral: Patient Activation
Behavioral: Provider Training
Behavioral: Quality Improvement
Behavioral: Community Outreach

First Posted Date: 2010-03-15

Last Posted Date: 2023-04-26

Lead Sponsor: University of Chicago

Target Recruit Count: 6209

Registration Number: NCT01087073

Locations: 🇺🇸
Kovler Diabetes Center, Chicago, Illinois, United States
🇺🇸
Chicago Family Health Center, Chicago, Illinois, United States
🇺🇸
University of Chicago, Primary Care Group, Chicago, Illinois, United States

and more 3 locations

Patient Acuity Rating: a Tool to Prevent In-Hospital Cardiac Arrest

Early Phase 1

Withdrawn

Conditions: Heart Arrest

Interventions: Other: Preemptive Rapid Response Team intervention

First Posted Date: 2010-03-09

Last Posted Date: 2016-04-07

Lead Sponsor: University of Chicago

Registration Number: NCT01082991

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

To Determine if a Lower Extremity Strengthening Program Improve Quadriceps Muscle Strength

Not Applicable

Completed

Conditions: Pulmonary Disease

Interventions: Other: Exercise

First Posted Date: 2010-03-04

Last Posted Date: 2014-12-04

Lead Sponsor: University of Chicago

Target Recruit Count: 40

Registration Number: NCT01080703

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Tysabri

First Posted Date: 2010-02-19

Last Posted Date: 2017-10-25

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT01071512

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

ACT-HF: Attention, Cognition and Self-Management in Heart Failure

Completed

Conditions: Heart Failure

First Posted Date: 2010-02-08

Last Posted Date: 2013-09-05

Lead Sponsor: University of Chicago

Target Recruit Count: 72

Registration Number: NCT01064765

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

N-Acetyl Cysteine in Pathologic Skin Picking

Phase 2

Completed

Conditions: Pathologic Skin Picking
Neurotic Excoriation
Psychogenic Excoriation
Dermatillomania

Interventions: Drug: N-Acetyl Cysteine
Drug: Placebo

First Posted Date: 2010-02-05

Last Posted Date: 2023-02-23

Lead Sponsor: University of Chicago

Target Recruit Count: 66

Registration Number: NCT01063348

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC

Phase 1

Terminated

Conditions: Non-Small Cell Lung Cancer

Interventions: Drug: RAD001 (in addition to standard radiation and chemotherapy)

First Posted Date: 2010-02-05

Last Posted Date: 2014-01-17

Lead Sponsor: University of Chicago

Target Recruit Count: 3

Registration Number: NCT01063478

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC

Not Applicable

Completed

Conditions: Advanced Non-squamous Non-Small Cell Lung Cancer

Interventions: Drug: Pemetrexed
Drug: Carboplatin
Drug: Bevacizumab 7.5 mg/kg
Drug: Bevacizumab 15 mg/kg

First Posted Date: 2010-02-05

Last Posted Date: 2019-11-18

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT01063283

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States
🇺🇸
Ingalls Memorial Hospital, Harvey, Illinois, United States
🇺🇸
North Shore University Health System, Evanston, Illinois, United States

Continuous Venovenous Hemofiltration Versus Continuous Venovenuous Hemodialysis

Not Applicable

Completed

Conditions: Acute Renal Failure

Interventions: Procedure: Continuous Venovenous Hemodialysis (CVVHD)
Procedure: Continuous Venovenous Hemofiltration (CVVH)

First Posted Date: 2010-02-04

Last Posted Date: 2023-05-10

Lead Sponsor: University of Chicago

Target Recruit Count: 11

Registration Number: NCT01062984

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy